20/09/2025
Scientists have achieved a groundbreaking milestone in the fight against HIV by developing a CRISPR-based therapy that removes HIV DNA from infected human cells and prevents the virus from returning. This revolutionary approach targets the viral genetic material directly, effectively erasing HIV from the cell’s genome and halting its ability to replicate.
In laboratory studies, treated cells showed no signs of viral rebound, offering a potential pathway toward a permanent cure for HIV, a disease that has affected millions globally. Unlike traditional antiretroviral therapies, which only suppress the virus, this CRISPR therapy tackles the root cause, providing hope for a one-time treatment with long-lasting effects.
Researchers emphasise that while early results are promising, further studies and clinical trials are required to ensure safety and efficacy in humans. If successful, this therapy could transform HIV treatment and bring the world closer to ending the HIV/AIDS epidemic once and for all.
